dc.contributor.author | Yalin, G. Y. | |
dc.contributor.author | Uzum, Ayşe Kubat | |
dc.contributor.author | Aral, F. | |
dc.contributor.author | Tanrikulu, S. | |
dc.contributor.author | Gul, Nurdan | |
dc.contributor.author | Tanakol, R. | |
dc.date.accessioned | 2021-03-03T08:51:45Z | |
dc.date.available | 2021-03-03T08:51:45Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Yalin G. Y. , Tanrikulu S., Gul N., Uzum A. K. , Aral F., Tanakol R., "Utility of baseline serum phosphorus levels for predicting remission in acromegaly patients", JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, cilt.40, sa.8, ss.867-874, 2017 | |
dc.identifier.issn | 1720-8386 | |
dc.identifier.other | av_19ecb4c0-9770-46ff-8049-123db6d5da49 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/22694 | |
dc.identifier.uri | https://doi.org/10.1007/s40618-017-0657-3 | |
dc.description.abstract | Purpose High GH and IGF I levels increase tubular phosphate reabsorption in patients with acromegaly. We aimed to investigate the utility of serum phosphorus levels as an indicator for predicting chance of remission in acromegaly patients. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
dc.title | Utility of baseline serum phosphorus levels for predicting remission in acromegaly patients | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 40 | |
dc.identifier.issue | 8 | |
dc.identifier.startpage | 867 | |
dc.identifier.endpage | 874 | |
dc.contributor.firstauthorID | 92142 | |